Meta-Analysis
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 28, 2020; 26(40): 6279-6294
Published online Oct 28, 2020. doi: 10.3748/wjg.v26.i40.6279
Table 1 Detailed tentative criteria for interpretation of the Japan Narrow-band-imaging Expert Team and Pit pattern classifications compared with histologic diagnosis
InterpretationJNETPit patternHistological diagnosisTherapeutic strategy
Non-neoplasticINormal mucosa
Type 1IIHyperplastic/SSLFollow-up observation
NeoplasticType 2AIIIL + IVAdenoma/LGDEndoscopic resection (polypectomy/EMR)
Type 2BIIIS + VI-LHGD/M-SM-s cancerEndoscopic resection (ESD)
Type 3VN + VI-HSM-d cancerSurgery
Table 2 General characteristics of the included studies
Ref.YearCountryStudy designPatients (n)Lesions (n)Type of endoscopyTypeof classificationCategory
Shibagaki et al[13]2020JapanRetrospective432718A-NBI-MEJNET/Pit pattern1/2A/2B/3; I, II, III/IV, VI-L, VI-H, VN
Kobayashi et al[5]2019JapanRetrospective7501402NBI-MEJNET/Pit pattern1/2A/2B/3; I, II, IIIL, IIIS, IV, IVH, VI-L, VI-H, VN
Sumimoto et al[14]2017JapanRetrospective19012933NBI-MEJNET1/2A/2B/3
Murano et al[15]2019JapanRetrospective6801472NBI-MEJNET1/2A/2B/3
Komeda et al[16]2017JapanRetrospective199199NBI-MEJNET1/2A/2B/3
Suzuki et al[17]2019JapanRetrospective145185BLI-MEJNET1/2A/2B/3
Hirata et al[18]2019JapanRetrospective61386138NBI-MEJNET1/2A/2B/3
Sakamoto et al[19]2019JapanRetrospective246246NBI-MEJNET1/2A/2B/3
Gonai et al[20]2020JapanRetrospective153169NBI-MEJNET2A/2B/3
Kawasaki et al[21]2019JapanRetrospective1717NBI-MEJNET/Pit pattern1/2A/2B/3; III, IV, VI-L, VI-H, VN
Nakano et al[23]2017JapanProspective506799BLI-MEPit patternII, IIIL, IIIS/IV, VI-L, VI-H/VN
Miroslaw et al[24]2015PolandProspective270386WL, NBI-MEPit patternI/II/IIIL/IIIS/IV/V
Su et al[25]2004ChinaProspective230270Magnifying chromoendoscopyPit patternI/II/IIIS/IIIL/IV/V
Kiesslich et al[26]2001GermanyProspective100283Magnifying chromoendoscopyPit patternI/II/IIIS/IIIL/IV/V
Kawaguti et al[27]2019BrazilProspective121123Magnifying chromoendoscopyPit patternII/IIIS/IIIL/IV/V
East et al[28]2008United KingdomProspective62116NBI-MEPit patternI/II/IIIS/IIIL/IV/V
Liu et al[29]2003ChinaProspective948954Magnifying chromoendoscopyPit patternI/II/IIIL/IIIS/IV/V
Kato et al[30]2006JapanProspective180210Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Van den Broek et al[31]2011NetherlandsProspective48153NBIPit patternNeoplastic/non-neoplastic
Togashi et al[32]2009JapanProspective50107Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Kiesslich et al[33]2003GermanyProspective84118Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Hurlstone et al[34]2005United KingdomProspective350288Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Tischendorf et al[35]2007GermanyProspective52100NBI-MEPit patternNeoplastic/non-neoplastic
Tischendorf et al[35]2007GermanyProspective47100Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Su et al[36]2006ChinaProspective79110ChromoendoscopyPit patternNeoplastic/non-neoplastic
Dos Santos et al[37]2012BrazilProspective69120Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Dos Santos et al[38]2010BrazilProspective72137Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Rogart et al[39]2008United StatesProspective131265NBIPit patternNeoplastic/non-neoplastic
Apel et al[40]2006GermanyProspective158273ChromoendoscopyPit patternNeoplastic/non-neoplastic
Van den Broek et al[41]2008NetherlandsProspective5098NBI-MEPit patternNeoplastic/non-neoplastic
Chiu et al[42]2007ChinaProspective133180Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Liu et al[22]2008ChinaRetrospective223451Magnifying chromoendoscopyPit patternNeoplastic/non-neoplastic
Table 3 Summary of the results of each category for the Japan Narrow-band-imaging Expert Team classification and the Pit pattern classification corresponding to histological diagnosis in the included studies
JNETSensitivitySpecificityDORAUCPit patternSensitivitySpecificityDORAUC
10.73 [0.55, 0.85]0.99 [0.97, 1.00]245 [64, 936]0.97 [0.95, 0.98]II0.76 [0.62, 0.86]0.96 [0.88, 0.98]68 [15, 309]0.92 [0.90, 0.94]
2A0.88 [0.78, 0.94]0.72 [0.64, 0.79]19 [11, 33]0.84 [0.81, 0.87]IIIL + IV0.80 [0.67, 0.89]0.80 [0.74, 0.86]17 [8, 34]0.87 [0.83, 0.89]
2B0.56 [0.47, 0.64]0.91 [0.79, 0.96]13 [7, 24]0.72 [0.68, 0.76]IIIS + VI-L0.45 [0.23, 0.69]0.88 [0.75, 0.94]6 [1, 26]0.79 [0.75, 0.82]
30.51 [0.42, 0.61]1.00 [1.00, 1.00]801 [267, 2398]0.90 [0.87, 0.93]VN + VI-H0.73 [0.55, 0.85]0.99 [0.98, 1.00]449 [93, 2182]0.98 [0.97, 0.99]
Non-neoplastic0.73 [0.55, 0.85]0.99 [0.97, 1.00]245 [64, 936]0.97 [0.95, 0.98]Non-neoplastic0.86 [0.81, 0.90]0.94 [0.90, 0.96]88 [48, 156]0.95 [0.93, 0.97]
Table 4 Summary of the results of Spearman’s correlation coefficient of each category for the Japan Narrow-band-imaging Expert Team classification and the Pit pattern classification corresponding to histological diagnosis in the included studies
JNET (type)CoefP valuePit pattern (type)CoefP value
Non-neoplastic-0.120.02
Type 1 (Non-neoplastic)0.140.02II0.450.20
Type 2A-0.700.49IIIL + IV-0.240.06
Type 2B-1.001.00IIIS + VI-L0.410.17
Type 3-0.170.03VN + VI-H1.001.00
Table 5 Summary of the results of meta-regression analysis of each category for the Japan Narrow-band-imaging Expert Team classification and the Pit pattern classification corresponding to histological diagnosis in the included studies
ClassificationTypeP value

ProdesignSampsizeQscoreEndoscopyCategoryCountryPubyear
JNETType 10.260.630.06
Type 2A0.880.580.760.00
Type 2B
Type 30.570.120.19
Pit patternII0.520.000.040.350.00
IIIL + IV0.630.770.410.330.770.000.09
IIIS + VI-L0.350.350.660.350.350.210.02
VN + VI-H
Non-neoplastic0.490.600.040.520.050.030.00
Table 6 Summary of the results of Deek’s test for publication bias of each category for the Japan Narrow-band-imaging Expert Team classification and the Pit pattern classification corresponding to histological diagnosis in the included studies
JNET (type)n of studyPubbias (P value)Pit pattern (type)No. of studyPubbias (P value)
Type 180.26II50.54
Type 2A100.62IIIL + IV100.41
Type 2B90.52IIIS + VI-L60.09
Type 390.50VN + VI-H80.91
Non-neoplastic80.26Non-neoplastic230.13